Search - tctmd.com

Displaying 241 - 260 of 336

Sort: Relevancy | Date

News Conference News EuroPCR 2016

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

Shelley Wood

May 20, 2016

News Industry News

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

May 16, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Yael L. Maxwell

May 02, 2016

News Daily News

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Yael L. Maxwell

May 02, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Daily News

Cuanto Más se Usa la TAVR, Más Atención se Pone en Estandarizar y Modernizar los Tratamientos

April 28, 2016

News Features

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

L.A. McKeown

April 18, 2016

News Opinion Editor's Corner ACC 2016

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

Shelley Wood

April 13, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Industry News

Successful Transapical Access and Closure Clinical Test Performed in 6 Consecutive Invivo Procedures Using the Heartstitch TA

March 09, 2016

News Daily News

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

L.A. McKeown

March 08, 2016

News Daily News

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

Todd Neale

March 06, 2016

News Daily News

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

Todd Neale

March 06, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News Stories for 2015

Shelley Wood

December 29, 2015

Advertisement

Embolic Protection in TAVR: If, When, What, and How Debated as Trials Wrap Up

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

Cuanto Más se Usa la TAVR, Más Atención se Pone en Estandarizar y Modernizar los Tratamientos

Asymptomatic Aortic Stenosis: The Next Frontier for TAVR?

Hot or Not, This Year’s Trials Offer Food for Thought: My Takeaways From ACC 2016

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Successful Transapical Access and Closure Clinical Test Performed in 6 Consecutive Invivo Procedures Using the Heartstitch TA

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

新的分析未能证实 CTO PCI 成功和死亡率降低之间存在关联

New Analysis Fails to Find Link Between Successful CTO PCI and Lower Mortality

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

TCTMD’s Top 10 Most Popular News Stories for 2015

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content